why choose us

First received: August 18, 2022

Clinical Trial: Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diabetic Kidney Disease

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of Two Doses of INV-202 in Patients With Diabetic Kidney Disease

Brief Summary: The study is designed to assess the efficacy, safety, tolerability, and transformation within the human body of INV-202 investigational drug in the treatment of adult participants with a diagnosis of Diabetic Kidney Disease due to either Type 1 diabetes mellitus or Type 2 diabetes mellitus

Read more